[Rheumatic mitral aggression. Usefulness of 3d transesophageal echocardiography]

Kelly Cupe-Chacalcaje1, Lindsay Benites-Yshpilco1, Angela Cachicatari-Beltrán1

  • 1. Hospital Nacional Guillermo Almenara, LimaPerú. Hospital Nacional Guillermo Almenara Lima Perú.

Insights

Rheumatic heart disease causes significant cardiovascular issues in young people globally. New 3D transesophageal echocardiography (TTE-3D) offers superior imaging for diagnosing mitral stenosis, improving upon traditional transthoracic echocardiography (TTE).

Area of Science:

  • Cardiology
  • Medical Imaging
  • Pediatric Cardiovascular Disease

Context:

  • Rheumatic heart disease (RHD) is a primary cause of pediatric cardiovascular disease, particularly in low-income nations.
  • Mitral stenosis is a common and critical manifestation of rheumatic heart disease.
  • Current diagnostic standards rely on transthoracic echocardiography (TTE), which has limitations in precise measurement and Doppler analysis.

Purpose:

  • To evaluate the efficacy of transesophageal 3D echocardiography (TTE-3D) in diagnosing mitral stenosis in rheumatic heart disease.
  • To compare the diagnostic capabilities of TTE-3D with conventional TTE.
  • To assess the ability of TTE-3D to accurately delineate the severity and anatomical details of mitral stenosis.

Summary:

  • Transesophageal 3D echocardiography (TTE-3D) provides realistic mitral valve visualization.
  • TTE-3D accurately identifies the plane of maximum stenosis.
  • This advanced imaging technique improves the assessment of commissural involvement in rheumatic mitral stenosis.

Impact:

  • TTE-3D offers enhanced diagnostic accuracy for rheumatic heart disease, particularly mitral stenosis.
  • Improved imaging may lead to more precise treatment strategies and better patient outcomes.
  • This technology has the potential to refine diagnostic guidelines for RHD globally.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
24
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
26
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
20
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
26
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14